These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
9. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura. Zeigler ZR; Kelton JG; Moore JC; Shadduck RK; Andrews DF; Nath R; Agha M Bone Marrow Transplant; 1999 Sep; 24(6):641-5. PubMed ID: 10490730 [TBL] [Abstract][Full Text] [Related]
10. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura. Kelton JG; Moore JC; Murphy WG Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308 [TBL] [Abstract][Full Text] [Related]
11. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207 [TBL] [Abstract][Full Text] [Related]
13. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura]. Chen SH Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093 [TBL] [Abstract][Full Text] [Related]
14. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069 [TBL] [Abstract][Full Text] [Related]
15. Platelet-agglutinating protein p37 from a patient with thrombotic thrombocytopenic purpura has characteristics similar to prethrombin 2. Kim SH; Park SJ; Lee JW; Jin JY J Biochem Mol Biol; 2002 Sep; 35(5):524-31. PubMed ID: 12359097 [TBL] [Abstract][Full Text] [Related]
16. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease. Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109 [TBL] [Abstract][Full Text] [Related]
18. Platelet activation in patients with thrombotic thrombocytopenic purpura. Hoffman M; Monroe DM; Roberts HR Am J Hematol; 1993 Feb; 42(2):182-5. PubMed ID: 7679878 [TBL] [Abstract][Full Text] [Related]
19. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Tandon NN; Rock G; Jamieson GA Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543 [TBL] [Abstract][Full Text] [Related]
20. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura. Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]